Watson wins OK for prostate drug
- Share via
From Times Wire Services
Watson Pharmaceuticals Inc. won U.S. approval to sell a prostate enlargement treatment as the Corona-based company tries to expand beyond manufacturing generic medicines.
The Food and Drug Administration cleared the once-a-day pill Rapaflo, Watson said. The drug is designed to reduce symptoms of an enlarged prostate including urinary pain.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
